NEW YORK, March 30, 2004 (PRIMEZONE) -- Amigula, Inc. (Pink Sheets:AMJL): The Rhode Island General Assembly is now considering legislation to permit the medical use of marijuana by seriously ill patients whose physicians have recommended it.
Warren B Eugene, President of Amigula, Inc. stated, "This is a very real -- sensible bill, it's a humane bill and it deserves special passage. There is overwhelming evidence that marijuana can relieve certain types of pain, nausea, vomiting as well as other symptoms caused by such illnesses as multiple sclerosis, cancer and AIDS. Often, harsh drugs are sometimes used to treat these illnesses in individuals -- many of these other drugs have terrible side effects. We have found in Canada that marijuana is less toxic than many of the drugs that physicians prescribe every day. Have you heard the disclaimers on well-known drugs, there a mile long? They're on every pharmaceutical commercial these days!
"It's true that there are other drugs that may work similar to marijuana, including Marinol, the pill containing THC (the main psychoactive chemical in marijuana)," stated Warren B Eugene. The truth: These other drugs don't work for everyone, perhaps 12% or less of the people they're prescribed to.
The Institute of Medicine noted: "It is well recognized that Marinol's oral route of administration hampers its effectiveness, because of slow absorption and patients' desire for more control over dosing."
Inhalation gives a more rapid response and better results. For some very sick people, marijuana simply works better.
About Amigula Inc.
Amigula Inc. (www.Amigula.com) has recently completed the purchase of 51% of Medical Cannabis Inc. and has announced their plans to file as a reporting issuer. The company plans to list on a major exchange beginning with an application for a listing on the American Stock Exchange (AMEX) or NASDAQ as well as several European exchanges. The company views the current prohibition of marijuana as similar to that of alcohol, beer and tobacco. Canada's marijuana crop alone is estimated at $4 billion to $7 billion. If a single company controlled it, it would be larger than Canada's oil and gas business and agricultural industries. On October 7, 2003 the Ontario Superior Court ruled that business and individuals be allowed to grow and supply medical marijuana, effectively relieving the Canadian government of it's often criticized and fairly unsuccessful attempts. Health Canada "permitted persons" (exemptees) can now pay Amigula to grow marijuana for them. The ruling makes it easier for sick people to get marijuana by allowing them easier access -- more choice and fair prices. The company has a mandate to develop and improve the medical marijuana business worldwide and is on the acquisition and consolidation trail of other legal licensed marijuana operations with notable international brands.
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.